A California-based marijuana company is preparing for its Canadian listing after waiting for the end of the grueling summer months.

On Friday (November 1), ManifestSeven issued a letter to investors indicating it will take the final steps for its public listing on the Canadian Securities Exchange (CSE); it was originally planned for September.


The company held off because a variety of critical developments for the marijuana investing space did not arrive until later in the year, including the legalization of edible and infused products in Canada and the passing of the SAFE Banking Act by US Congress.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In the letter to investors, ManifestSeven Director and CEO Sturges Karban said the company is now working to update its original initial application form — which was filed with the CSE in May — since the company has advanced its position from earlier in the year.

Karban said the company anticipates approval of its application within a few weeks from official filing.

The executive said ManifestSeven was initially aiming to file its application right after the Labor Day holiday in the US when, according to him, “the global markets would presumably begin reemerging from their seasonal inertia.” Ultimately the firm decided to wait.

Despite the state of the investment landscape for marijuana plays, Karban said he is excited about the position his company is in.

“Upon surveying and analyzing the most distressed publicly-traded cannabis companies today, it is evident that almost all the recent fallout in the marketplace has resulted from self-inflicted and avoidable problems that are not applicable in the case of (ManifestSeven),” he said.

According to the executive, these issues in the market include: persistent undercapitalization, reckless cost structures (usually inclusive of excessive executive compensation) and onerous financing transactions.

ManifestSeven made headlines recently after it commissioned a study on sentiment surrounding marijuana stocks from high-end investors.

The report indicates a high level of confidence from current investors about their chances of making back their money based on the state of the market.

“Investors are seeing the industry’s first major market correction,” said Karban. “And yet, 71 percent of retail investors in the US and 73 percent in Canada say they expect investment in the cannabis industry to significantly grow over the next 12 months.”

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann (CSE:AYUR) provides scalable custom processes and pharma-grade products to the medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by delivering best-in-class, proprietary services, including ethanol extraction, formulation, product development and custom manufacturing.

The company offers a two-tier business model of services and production. The manufacturing vertical offers three production divisions specializing in expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing. Ayurcann currently extracting approximately 1,500 kilograms a week of product and has the capacity to process up to 200,000 kilograms of dry cannabis annually.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 87th nationwide.

The dispensary supports Trulieve’s goal of ensuring direct, reliable access to registered medical cannabis patients across Florida and joins nearby locations in Sarasota , Englewood , and Venice . The 5,300 square foot facility also brings direct, in-store access to registered patients in Osprey for the first time.

Keep reading... Show less

Global demand for plant-based functional products accelerating plan to scale the brand internationally

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) is excited to announce the anticipated launch of its market-leading TRACE brand in the U.S., initially through its new e-commerce website and subsequently in natural specialty and retail stores nationally.

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV) (OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of a new medical dispensary in Olympia Heights, Florida .

Keep reading... Show less

Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that its previously announced lab services agreement with Numinus Wellness Inc. (“Numinus“) (TSXV: NUMI) is progressing forward with an initial candidate for clinical trials, subject to Health Canada approvals.

Recognized as a global leader in supporting and expanding the safe, accessible, and evidence-based use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of all-natural, Canadian-grown psilocybin-producing mushrooms and related product formulations.

Keep reading... Show less